270 related articles for article (PubMed ID: 33126868)
21. A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant.
Zhao YY; Chen SH; Wan QS
Medicine (Baltimore); 2019 Nov; 98(46):e17903. PubMed ID: 31725638
[TBL] [Abstract][Full Text] [Related]
22. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
Bagante F; Tran T; Spolverato G; Ruzzenente A; Buttner S; Ethun CG; Groot Koerkamp B; Conci S; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Vitiello G; IJzermans JN; Maithel SK; Poultsides G; Guglielmi A; Pawlik TM
J Am Coll Surg; 2016 May; 222(5):750-759.e2. PubMed ID: 27113512
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
24. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
25. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
26. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
27. Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study.
Tang CT; Zeng L; Yang J; Zeng C; Chen Y
BMC Cancer; 2020 Jun; 20(1):608. PubMed ID: 32600342
[TBL] [Abstract][Full Text] [Related]
28. Predictive performance of Blumgart T staging for perihilar cholangiocarcinoma in a Japanese center.
Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Nagino M
J Hepatobiliary Pancreat Sci; 2020 Mar; 27(3):132-140. PubMed ID: 31654600
[TBL] [Abstract][Full Text] [Related]
29. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients.
Li M; Li K; Qi X; Wu W; Zheng L; He C; Yin Z; Fan D; Zhang Z; Han G
J Vasc Interv Radiol; 2016 Jul; 27(7):1047-1055.e2. PubMed ID: 27241392
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
[TBL] [Abstract][Full Text] [Related]
32. The impact of post-hepatectomy liver failure on long-term survival after liver resection for perihilar cholangiocarcinoma.
Sarkhampee P; Ouransatien W; Chansitthichok S; Lertsawatvicha N; Wattanarath P
HPB (Oxford); 2024 Jun; 26(6):808-817. PubMed ID: 38467530
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.
Song W; Lv CG; Miao DL; Zhu ZG; Wu Q; Wang YG; Chen L
Eur J Surg Oncol; 2018 Oct; 44(10):1657-1665. PubMed ID: 30082175
[TBL] [Abstract][Full Text] [Related]
37. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes.
Conci S; Ruzzenente A; Sandri M; Bertuzzo F; Campagnaro T; Bagante F; Capelli P; D'Onofrio M; Piccino M; Dorna AE; Pedrazzani C; Iacono C; Guglielmi A
Eur J Surg Oncol; 2017 Apr; 43(4):743-750. PubMed ID: 28094085
[TBL] [Abstract][Full Text] [Related]
38. A new clinically based staging system for perihilar cholangiocarcinoma.
Chaiteerakij R; Harmsen WS; Marrero CR; Aboelsoud MM; Ndzengue A; Kaiya J; Therneau TM; Sanchez W; Gores GJ; Roberts LR
Am J Gastroenterol; 2014 Dec; 109(12):1881-90. PubMed ID: 25384902
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
